Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Submitted by
admin
on February 8, 2018 - 11:17am
Source:
Market Realist
News Tags:
AbbVie
R&D
immunology
Upadacitinib
risankizumab
Headline:
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Do Not Allow Advertisers to Use My Personal information
